| 000 | 01919 a2200589 4500 | ||
|---|---|---|---|
| 005 | 20250516214210.0 | ||
| 264 | 0 | _c20140925 | |
| 008 | 201409s 0 0 eng d | ||
| 022 | _a1528-0020 | ||
| 024 | 7 |
_a10.1182/blood-2014-01-550244 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHie, Miguel | |
| 245 | 0 | 0 |
_aPreemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura. _h[electronic resource] |
| 260 |
_bBlood _cJul 2014 |
||
| 300 |
_a204-10 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aADAM Proteins _xblood |
| 650 | 0 | 4 | _aADAMTS13 Protein |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xadministration & dosage |
| 650 | 0 | 4 |
_aAutoantibodies _xblood |
| 650 | 0 | 4 |
_aChemoprevention _xmethods |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPurpura, Thrombotic Thrombocytopenic _xblood |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aSecondary Prevention |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aGay, Julie | |
| 700 | 1 | _aGalicier, Lionel | |
| 700 | 1 | _aProvôt, François | |
| 700 | 1 | _aPresne, Claire | |
| 700 | 1 | _aPoullin, Pascale | |
| 700 | 1 | _aBonmarchand, Guy | |
| 700 | 1 | _aWynckel, Alain | |
| 700 | 1 | _aBenhamou, Ygal | |
| 700 | 1 | _aVanhille, Philippe | |
| 700 | 1 | _aServais, Aude | |
| 700 | 1 | _aBordessoule, Dominique | |
| 700 | 1 | _aCoindre, Jean-Philippe | |
| 700 | 1 | _aHamidou, Mohamed | |
| 700 | 1 | _aVernant, Jean-Paul | |
| 700 | 1 | _aVeyradier, Agnès | |
| 700 | 1 | _aCoppo, Paul | |
| 773 | 0 |
_tBlood _gvol. 124 _gno. 2 _gp. 204-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2014-01-550244 _zAvailable from publisher's website |
| 999 |
_c23863652 _d23863652 |
||